Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00030420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Celecoxib
DRUG: Docetaxel

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]